DUBLIN, July 1, 2015 /PRNewswire/ -- Jazz Pharmaceuticals
plc (Nasdaq: JAZZ) today announced that the company will be
webcasting its corporate presentation at the Cantor Fitzgerald
Healthcare Conference in New York,
NY.
Russell Cox, executive vice
president and chief operating officer, will provide an overview of
the company and a business and financial update on Wednesday, July 8, 2015 at 9:30 a.m. EDT / 2:30 p.m.
IST.
A live audio webcast of the presentation may be accessed from
the Investors & Media section of the Jazz Pharmaceuticals
website at www.jazzpharmaceuticals.com. Please connect to the
website prior to the start of the presentation to ensure adequate
time for any software downloads that may be necessary to listen to
the webcast.
An archive of the webcast will be available for at least one
week following the presentation on the Investors & Media
section of the company's website at
www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is an international
biopharmaceutical company focused on improving patients' lives by
identifying, developing and commercializing meaningful products
that address unmet medical needs. The company has a diverse
portfolio of products and/or product candidates with a focus in the
areas of sleep and hematology/oncology. In these areas, Jazz
Pharmaceuticals markets Xyrem® (sodium oxybate) oral solution and
Erwinaze® (asparaginase Erwinia chrysanthemi) in the U.S.,
and markets Erwinase® and Defitelio® (defibrotide) in Europe and other countries outside the U.S.
For more information, please visit www.jazzpharmaceuticals.com.